Internal Medicine, Hematology & Oncology · Los Alamitos, CA
NPI
1750585345
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
3822 Katella Ave Ste 200
Los Alamitos, CA, 90720
Phone (562) 735-0602
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
57,047 services
Medicare patients, 2024
391
Average age 75
Drug cost, 2024
$4.1M
1,747 prescriptions
Company payments, 2025
$9,150
From 67 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nihal E Abdulla was code J0897 (injection, denosumab, 1 mg), 4,800 times for 27 patients. In total Nihal E Abdulla billed 57,047 services in 90 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,800 | 27 | $20.67 | $99K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 3,100 | 27 | $16.08 | $50K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 605 | 12 | $0.09 | $53.81 |
| 99215 Office E&M - Established | Office | 330 | 106 | $149.51 | $49K |
| 99233 Hospital E&M - Subsequent | Facility | 316 | 128 | $97.26 | $31K |
| 99214 Office E&M - Established | Office | 295 | 154 | $100.85 | $30K |
| 99232 Hospital E&M - Subsequent | Facility | 228 | 99 | $64.78 | $15K |
| 96372 Injection Administration | Office | 181 | 41 | $12.42 | $2,247 |
| 96367 Intravenous Infusion, Hydration | Office | 121 | 19 | $25.08 | $3,034 |
| 99231 Hospital E&M - Subsequent | Facility | 118 | 28 | $40.56 | $4,786 |
| 99223 Hospital E&M - Initial | Facility | 104 | 94 | $141.48 | $15K |
| 96413 Chemotherapy Administration | Office | 100 | 18 | $115.80 | $12K |
| 96365 Intravenous Infusion, Hydration | Office | 92 | 37 | $56.17 | $5,167 |
| 99205 Office E&M - New | Office | 41 | 41 | $180.02 | $7,381 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 28 | 11 | $0.63 | $17.77 |
By year: 2022 $1.6M for 81,314 services; 2023 $1.2M for 83,434 services; 2024 $1.2M for 57,047 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 15 | 11 | $4.90 | $73.5 |
Medicare prescription drug claims, 2024
In 2024, the drug Nihal E Abdulla prescribed most often to Medicare patients was Tamoxifen Citrate, with 131 prescriptions and refills. In total Nihal E Abdulla wrote 1,747 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamoxifen Citrate Generic | 131 | 287 | 38 | $4,489 |
| Prednisone Generic | 116 | 134 | 31 | $559 |
| Anastrozole Generic | 110 | 257 | 28 | $2,412 |
| Abiraterone Acetate Generic | 81 | 81 | 12 | $301K |
| Letrozole Generic | 80 | 162 | 23 | $1,837 |
| Ondansetron Odt Ondansetron | 75 | 75 | 51 | $1,173 |
| Eliquis Apixaban | 72 | 152 | 21 | $84K |
| Dexamethasone Generic | 69 | 79 | 35 | $1,344 |
| Procrit Epoetin Alfa | 59 | 59 | 13 | $64K |
| Hydroxyurea Generic | 52 | 116 | 14 | $1,433 |
| Xarelto Rivaroxaban | 39 | 77 | Under 11 | $41K |
| Famotidine Famotidine/Pf | 37 | 37 | Under 11 | $47.15 |
| Dexamethasone Sodium Phosphate Generic | 32 | 32 | Under 11 | $39.56 |
| Diphenhydramine Hcl Generic | 27 | 27 | Under 11 | $46.01 |
| Revlimid Lenalidomide | 25 | 25 | Under 11 | $443K |
Brand drugs: 504 claims; generic drugs: 1,243 claims; opioid claims: 44.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nihal E Abdulla $9,150 ($9,150 in general payments such as food, travel and fees) from 67 companies. The largest payer was Janssen Biotech, Inc. with $2,415.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 14 | $2,415 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $1,080 |
| AstraZeneca Pharmaceuticals LP AZN | 22 | $590 |
| Celgene Corporation BMY | 24 | $420 |
| Pfizer Inc. PFE | 23 | $398 |
| E.R. Squibb & Sons, L.L.C. BMY | 23 | $342 |
| Cardinal Health 110 LLC | 1 | $275 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $260 |
| Incyte Corporation INCY | 12 | $231 |
| Merck Sharp & Dohme LLC MRK | 7 | $208 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.